Skip to content
Recall Observatory FDA recall evidence

Drug product

ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01

D-1546-2022

August 23, 2022

Class III

Product summary

Firm
Leading Pharma, LLC
Event
Event 90853
Status
Terminated
Classification
Class III
Quantity
960 bottles (100 capsules)
Official record key
drug-enforcement:D-1546-2022

Official wording

Reason: Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules

Code information: Lot#: B14221, Exp. Date 02/2023

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent